ALIFE2 study: Low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia - study protocol for a randomized controlled trial

Paulien G. de Jong*, Siobhan Quenby, Kitty W.M. Bloemenkamp, Babette A.M. Braams-Lisman, Peter J. de Bruin, Arri Coomarasamy, Michele David, Maria T. DeSancho, Olivier W.H. van der Heijden, Annemieke Hoek, Barbara A. Hutten, Kristin Jochmans, Carolien A.M. Koks, Walter K.H. Kuchenbecker, Willem B. Mol, Helen L. Torrance, Hubertina C.J. Scheepers, Mary D. Stephenson, Harold R. Verhoeve, Jantien VisserJohanna I.P. de Vries, Mariëtte Goddijn, Saskia Middeldorp

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)

Fingerprint

Dive into the research topics of 'ALIFE2 study: Low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia - study protocol for a randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences